Description

(1R,5S,7S)-6-tert-Butyl 7-Ethyl 3,6-Diazabicyclo[3.2.1]Octane-6,7-Dicarboxylate is a high-purity, advanced pharmaceutical intermediate of significant importance in modern synthetic chemistry. This compound serves as a critical chiral building block for the development of complex active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular architectures. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in the synthesis of novel drug candidates, especially those targeting central nervous system (CNS) disorders and other specialized medicinal applications.

Application

• Key chiral intermediate in the synthesis of complex pharmaceutical compounds.
• Building block for the development of novel Active Pharmaceutical Ingredients (APIs) targeting neurological pathways.
• Precursor in medicinal chemistry research for structure-activity relationship (SAR) studies.
• Critical component in the production of high-value fine chemicals and specialty materials.
• Research chemical for academic and industrial R&D in asymmetric synthesis and catalysis.
• Starting material for the preparation of other functionalized diazabicyclooctane derivatives.

Basic Information

Item	Details
Product Name	(1R,5S,7S)-6-tert-Butyl 7-Ethyl 3,6-Diazabicyclo[3.2.1]Octane-6,7-Dicarboxylate
CAS No.	1251012-84-6
Molecular Formula	C16H28N2O4
Molecular Weight	312.41 g/mol
Synonyms	6-tert-Butyl 7-ethyl 3,6-diazabicyclo[3.2.1]octane-6,7-dicarboxylate; (1R,5S,7S)-6-Boc-7-COOEt-3,6-diazabicyclo[3.2.1]octane; tert-Butyl ethyl 3,6-diazabicyclo[3.2.1]octane-6,7-dicarboxylate; Bicyclic diaza compound 1251012-84-6; Chiral diazabicyclooctane diester; DBCO derivative intermediate; Pharmaceutical intermediate CAS 1251012-84-6
EINECS	Contact for details

Quality Control

Our (1R,5S,7S)-6-tert-Butyl 7-Ethyl 3,6-Diazabicyclo[3.2.1]Octane-6,7-Dicarboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including chiral purity verification by HPLC, to ensure it meets the high standards required for pharmaceutical R&D and production. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This material is hygroscopic (moisture-sensitive) and must be kept under dry, inert conditions to prevent degradation. For long-term storage, consider using desiccants and maintaining an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.